U.S. Antiarrhythmic Drugs Market to Reach USD 0.51 Billion by 2032, Growing at 6.28% CAGR as Hospitals and Healthcare Providers Expand Access to Life-Saving Antiarrhythmic Therapies.Pune, Sept. 12, ...

Key Insights Spectra Systems' estimated fair value is UK£2.48 based on 2 Stage Free Cash Flow to Equity Spectra ...